Auxly Cannabis Group Inc. · TSX:XLY
Auxly Cannabis — Q4 2025 Earnings Presentation
27 slides from Auxly Cannabis's earnings presentation, Mar 27, 2026
Slide 1: Investor Presentation
Investor Presentation March 2026 TSX: XLY OTCQB: CBWTF www.auxly.com
Slide 2: Disclaimer
Disclaimer Legal Disclaimer The information provided herein is not intended to provide financial, tax, legal or accounting advice. The contents hereof do not constitute an offer to sell or a solicitation of an offer to buy securities of Auxly Cannabis Group Inc. (the “Company”) or represent an inten
Slide 3: Our Mission and Vision
OUR MISSION is to help people live happier lives by providing them with quality cannabis products that they trust and love OUR VISION is to be a global leader in cannabis products
Slide 4: Auxly at a Glance
Founded: 2017 Auxly at a Glance HQ: Toronto, Ontario TSX: XLY | OTCQB: CBWTF Putting People First Our Brands Growing and Profitable #1 BRAND IN 400+ CANADA $152M 2025 net revenue up 24% YoY passionate team members Coast to Coast Reach $44M 2025 Adjusted EBITDA up 64% YoY Global Strategic Partnership
Slide 5: The Great Cannabis Opportunity
The Great Cannabis Opportunity
Slide 6: Canadian Recreational Market
Canadian Recreational Market | 2nd largest cannabis market in the world | CAD$7.4B 2030 TAM in Canada1 56% 12% 72% Of Canadians find Growth in recreational Of cannabis consumers cannabis socially cannabis sales YoY, purchased from a legal acceptable; up from whereas alcohol sales source in 2024 44%
Slide 7: A Growing Global Opportunity
A Growing Global Opportunity | Canada as a launchpad for global leadership | US$134B Why Canada? Global Legal Cannabis Market in 20301 Capital and infrastructure advantage and largest exporter of cannabis globally Valuable IP, genetics and expertise developed in a highly regulated market Strategic p
Slide 8: Auxly Cannabis Group
KU ALT Foray Parcel Dosecann 34 $24
Slide 9: Homegrown Success, Market Leadership
Homegrown Success, Market Leadership | Trusted Brands, Winning Assets, Sustainably Profitable | #1 Best-selling non- #1 #1 Best-selling all-in- Best-selling flower infused pre-roll one vape brand brand brand #3 2 State-of-the art 10 Consecutive ALL CATEGORIES LP in Canada quarters of positive facili
Slide 10: Auxly Leamington
Auxly Leamington | World-class 1.1 million sq. ft. cultivation facility | • Highly automated purpose-built with advanced lighting, temperature, and humidity control, powered by state-of-the-art technology • Annual production of over 100,000 kgs, with ability to scale within existing footprint and 40
Slide 11: #1 Dried Flower Brand
#1 Dried Flower Brand National R3M December 2025 11
Slide 12: Pre-roll Automation
Pre-roll Automation | Consistent, high-quality pre-rolls at scale | • Advanced high-speed cannabis pre-roll filling and packaging capabilities • 5-year R&D partnership with world’s largest manufacturer of tobacco manufacturing equipment • Unrivaled operational and technical know-how • Strain-specifi
Slide 13: #1 Non-Infused Pre-Roll Brand
#1 Non-Infused Pre-Roll Brand National R3M December 2025 13
Slide 14: Auxly Charlottetown
Auxly Charlottetown | 52,000 sq. ft. manufacturing facility | • Purpose-built for vape manufacturing and product development • 5+ years of leadership in first-to-market, category-defining innovations • Fully licensed for processing, sales, analytical and sensory testing • Recognized as industry lead
Slide 15: #1 Disposable Vape Brand
#1 Disposable Vape Brand National R3M December 2025 15
Slide 16: Latest Innovations: Introducing Southpoint
Latest Innovations | Introducing Southpoint | INTRODUCING 16
Slide 17: Latest Innovations: All-in-One Boosted
Latest Innovations | Introducing All-in-One Boosted | 17
Slide 18: Financial Overview
Financial Overview GAGKEORTS {ITI Foray Parcel BOINT™
Slide 19: Q4 2025 Summary
Q4 2025 Summary | Strong profitability with a 31% EBITDA margin | Summary Income Statement Quarterly Net Revenue vs. Adjusted EBITDA (CAD $000s) Q4 2025 Q4 2024 Chg. % FY 2025 FY 2024 Chg. % (CAD $000s) Net Revenue 40,113 34,626 16% 151,482 122,329 24% Cannabis Inventory GM 22,637 18,684 21% 81,102
Slide 20: Improving YoY Financial Performance
Improving YoY Financial Performance Gross Margin on Finished Cannabis Net Revenue Adjusted EBITDA Inventory Sold (CAD $000s) (CAD $000s) | (% of NOR) (CAD $000s) 24% $81,102 64% $151,482 $43,787 21% 1,715% $122,329 $55,861 54% $101,078 $26,705 46% $34,295 34% $1,471 2023 2024 2025 2023 2024 2025 202
Slide 21: Generating Sustainable Cash Flow
Generating Sustainable Cash Flow Cash Flow from Operations Cash Flow from Operations Before Net Working Capital Changes After Net Working Capital Changes (CAD $000s) (CAD $000s) $38,564 Cash flow from operations Capex 26,194 $16,872 16,778 8,214 1,604 2,763 2,516 2023 2024 2025 2023 2024 2025 -$9,65
Slide 22: Building to Last
Building to Last | A clear path to value creation and continued growth | Products and brands that consumers trust and love • Winning at home with #1 brand in Canada • Leadership in largest product categories World-class assets and capabilities • Large scale cultivation and manufacturing • Award winn
Slide 23: Appendices
Appendices GAGK FORTS {IIE Foray Parcel Dosecann HE SOUTH
Slide 24: Q4 2025 Non-GAAP Supplemental Information
Q4 2025 Non-GAAP Supplemental Information | Net Income to Adjusted EBITDA Reconciliation | Three months ended December 31 (CAD $000s) Q4 2023 Q4 2024 Q4 2025 Net Income/(loss) $ (54,020) $ 4,423 $ 943 Interest and accretion expenses $ 6,837 $ 2,291 $ 1,222 Interest and other income (22) (27) (25) In
Slide 25: 2025 Non-GAAP Supplemental Information
2025 Non-GAAP Supplemental Information | Net Income to Adjusted EBITDA Reconciliation | Twelve months ended December 31 (CAD $000s) 2023 2024 2025 Net Income/(loss) $ (44,511) $ (16,348) $ 41,855 Interest and accretion expenses $ 25,715 $ 15,041 $ 6,658 Interest and other income (32) (240) (130) Inc
Slide 26: Capitalization Table
Capitalization Table As of December 31, 2025 Issued and Outstanding Shares Outstanding shares 1,365,150,373 Escrowed shares 1,888,421 Total Issued and Outstanding Shares 1,367,038,794 Outstanding Securities Warrants 159,185,118 Options 15,131,169 Restricted share units 156,878,213 Total Outstanding
Slide 27: Auxly Cannabis Group
Auxly Cannabis Group 777 Richmond St W Unit 002 Toronto Ontario M6J 0C2 TSX: XLY OTCQ: CBWTF www.auxly.com Investor Relations Direct Line +1.647.812.0121 Facsimile Line +1.855.669.7881 Email info@auxly.com